Evidence map›Paper›PMID 38965331›Full record

ArticleNature microbiology2024

Enterococcus faecalis-derived adenine enhances enterohaemorrhagic Escherichia coli Type 3 Secretion System-dependent virulence.

Fernando H Martins, Thibaut Rosay, Anubama Rajan, Hannah E Carter, Tayah Turocy, Andres Mejia, Jason M Crawford, Anthony W Maresso, Vanessa Sperandio

Abstract read
In one paragraph

Article in Nature microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Multidrug-ResistantVeterinary sciences · 2025
    Article
  6. Article
  7. Foods (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fernando H Martins *Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Thibaut Rosay *Department of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI, USA.
Anubama RajanTAILOR Labs, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Hannah E CarterTAILOR Labs, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Tayah TurocyDepartment of Chemistry, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-5197-0264
Andres MejiaResearch Animal Resources and Compliance, University of Wisconsin-Madison, Madison, WI, USA.
Jason M CrawfordDepartment of Chemistry, Yale University, New Haven, CT, USA.ORCID http://orcid.org/0000-0002-7583-1242
Anthony W MaressoTAILOR Labs, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Vanessa SperandioDepartment of Medical Microbiology and Immunology, University of Wisconsin-Madison, Madison, WI, USA. vsperandio@wisc.edu.ORCID http://orcid.org/0000-0003-0819-7904

Funding

Quorum sensing regulation of EHEC virulence genesR01AI053067 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI SPERANDIO, VANESSA · 2003 to 2017
$6.3M
Quorum Sensing Regulation of EHEC Virulence GenesR37AI053067 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI VANESSA SPERANDIO · 2018 to 2026
$5.3M
Sugar regulation of EHEC virulenceR01AI154597 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI MARESSO, ANTHONY W, SPERANDIO, VANESSA · 2020 to 2024
$3.1M
Tryptophan derivatives in EHEC pathogenesisR01AI155398 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI SPERANDIO, VANESSA · 2021 to 2025
$3.0M
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI053067Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI154597Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Division of Intramural Research of the NIAID) AI155398NIAID NIH HHS R01 AI053067NIAID NIH HHS R01 AI154597NIAID NIH HHS R01 AI155398NIAID NIH HHS R37 AI053067
6 · The paper itself

Abstract

Interactions between microbiota and enteric pathogens can promote colonization resistance or enhance pathogenesis. The pathobiont Enterococcus faecalis increases enterohaemorrhagic E. coli (EHEC) virulence by upregulating Type 3 Secretion System (T3SS) expression, effector translocation, and attaching and effacing (AE) lesion formation on enterocytes, but the mechanisms underlying this remain unknown. Using co-infection of organoids, metabolomics, supplementation experiments and bacterial genetics, here we show that co-culture of EHEC with E. faecalis increases the xanthine-hypoxanthine pathway activity and adenine biosynthesis. Adenine or E. faecalis promoted T3SS gene expression, while transcriptomics showed upregulation of adeP expression, which encodes an adenine importer. Mechanistically, adenine relieved High hemolysin activity (Hha)-dependent repression of T3SS gene expression in EHEC and promoted AE lesion formation in an AdeP-dependent manner. Microbiota-derived purines, such as adenine, support multiple beneficial host responses; however, our data show that this metabolite also increases EHEC virulence, highlighting the complexity of pathogen-microbiota-host interactions in the gut.

Indexed as

AdenineEnterococcus faecalisEnterohemorrhagic Escherichia coliGene Expression Regulation, BacterialType III Secretion SystemsAnimalsCoculture TechniquesEnterocytesEscherichia coli InfectionsEscherichia coli ProteinsGastrointestinal MicrobiomeHemolysin ProteinsHost-Pathogen InteractionsHumansHypoxanthineMiceAdenineEscherichia coli ProteinsHemolysin ProteinsHypoxanthineType III Secretion SystemsVirulence FactorsXanthine

Identifiers

PMID38965331
PMCPMC11585081

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.